The ESCMID Journal, Clinical Microbiology and Infection (CMI), is seeking to fill the role of editor-in-chief. For more information on the role, qualifications and application process, see the job advert under Jobs/Talents on the ESCMID webpage.

The open call for applications will close on 31 January 2025.

Science & Research

We are pleased to announce an open call for two new members of the ESCMID Ethics Advisory Committee. The officer’s term is from April 2025 to April 2029 (after ESCMID Global).

Have a role in counselling on specific ethical, regulatory, social and philosophical issues related to ESCMID funded-research projects, as well as scientific behaviour of members or appointed persons in matters related to ESCMID activities.

Education

This comprehensive course equips healthcare professionals with the tools to identify, communicate, and manage risks effectively. Gain insights into fostering a safety culture, mastering evidence-based risk management strategies, and promoting interprofessional collaboration. Whether you are aiming to enhance team communication or implement cutting-edge tools for patient safety, this program is your pathway to excellence.

This course is part of the ESCMID EUCIC Certificate Programme.

Explore how the microbiome shapes health, disease susceptibility, and therapeutic innovation. From immune modulation to resistance against pathogens, delve into groundbreaking research and learn to interpret complex bioinformatics, metagenomics, and metabolomics data. Don’t miss this opportunity to stay at the forefront of medical science – register now!

Congress & Events

We thank all creative minds from all over the world who contributed with their outstanding pieces for the Art Gallery of ESCMID Global 2025.

This year’s theme is Climate Change and Infection. You can now check out the final book with all art pieces on the ESCMID Global website.

Guidelines & Journals

Sexually transmitted infections (STIs) affect millions globally daily, and multidrug-resistant strains are complicating treatment. This episode reviews the latest epidemiology and highlights the need to innovate diagnostics and treatment options, destigmatise STIs, and promote people-centred healthcare strategies to manage and prevent some common STIs.

Efficacy and safety of single-dose suraxavir marboxil tablet in the treatment of acute uncomplicated influenza in adults: a multi-center, randomized, double-blind, placebo-controlled phase 2 clinical trial

Immunity to urinary tract infection: what the clinician should know